Test Price
1,200 AEDโ Home Collection Available
Beta Thalassemia โ 12 Common Mutations Screening (Single) in UAE | 1200 AED | DHA Compliant
Executive Summary & Core Metrics
Executive Summary: Highly accurate molecular screening for 12 common HBB gene mutations using endpoint PCR with 99.9% diagnostic sensitivity. This test is processed in a DHA-licensed, ISO 9001:2015 accredited facility, and includes VIP Mobile Phlebotomy home collection with temperature-controlled cold-chain transport. Patients receive telephonic post-test clinical guidance and direct billing verification via WhatsApp at +971 54 548 8731.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Beta Thalassemia 12 Common Mutations Screening (Single) test employs Endpoint Polymerase Chain Reaction (PCR) to detect the 12 most prevalent mutations in the HBB gene. This molecular diagnostic approach identifies specific genetic variants responsible for beta-thalassemia, enabling precise carrier detection and early clinical diagnosis. The method is validated against international standards and processed within an ISO 9001:2015 certified laboratory environment.
| Feature | Our Test (Precision/Method/Speed) | Closest Alternative (Hemoglobin Electrophoresis) |
|---|---|---|
| Molecular Resolution | Identifies exact mutation (12 most prevalent HBB variants) | Detects abnormal hemoglobin but cannot specify mutation |
| Diagnostic Sensitivity | 99.9% (ISO 9001:2015 validated) | Approximately 85-90% for beta-thal traits |
| Turnaround Time | 6-7 working days | 1-2 days (screening only, often needs DNA confirmation) |
| Regulatory Status | DHA-compliant, Federal Decree-Law No. 45 of 2021 referenced | Standard clinical lab license |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics specialist, I emphasize that this genetic test should be interpreted within the full clinical context, including family history and hematological indices. A positive mutation result may indicate carrier status or disease, but it is not a standalone diagnosis. All findings must be correlated with a complete blood count and hemoglobin electrophoresis, and patients should consult a genetic counselor for comprehensive risk assessment."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notes & Medication Considerations
Do not discontinue any prescribed medication, including iron chelation therapy or folic acid, without explicit consultation with your treating physician. Genetic test results provide additional diagnostic information but do not replace the need for ongoing clinical management. For patients on regular transfusion protocols, a washout period of at least 3 months from the last transfusion is required before testing to avoid false negative results.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent blood transfusion (within 3 months) may mask carrier status; reschedule after washout period.
- Exclusion: Inability to provide a peripheral blood sample due to severe anemia or medical contraindication.
- Emergency Red Flags: Severe pallor, jaundice, rapid heartbeat (tachycardia), bone deformities, or acute hemolytic crisis โ seek immediate in-person medical evaluation before scheduling a genetic test.
Patient FAQ & Clinical Guidance
1. Why should I consider this test if I have a family history of thalassemia?
If you have a family history of thalassemia, this test accurately identifies your carrier status for the 12 most common beta-globin mutations. Knowing your carrier status is crucial for reproductive planning and early intervention. The test uses endpoint PCR, a clinically validated molecular method with near-perfect sensitivity. A formal genetic counseling session is recommended upon receipt of results to discuss reproductive options and family planning strategies.
2. How long does it take to receive results and what is the process?
Results are delivered within 6-7 working days via secure patient portal after home blood collection and transport in validated cold-chain. Our VIP mobile phlebotomist arrives at your preferred location (8 AM โ 11 PM), draws a single peripheral blood sample, and the specimen is immediately processed in our ISO 9001:2015 certified laboratory. You will receive a notification via SMS and email once your report is available for secure download.
3. Is a doctorโs prescription mandatory for this genetic screening?
A doctorโs prescription is required for this genetic test, except for pre-surgical clearance, pregnancy cases, or travel abroad, where direct booking is permitted. This policy aligns with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection and DHA guidelines to ensure appropriate clinical oversight. For minors, additional parental consent and documentation are mandatory as per UAE law.
UAE Regulatory & Data Privacy Adherence
Legal & Privacy Compliance: This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All patient data is encrypted and processed within a DHA-licensed facility (License: 1143). The laboratory holds ISO 9001:2015 Certification (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Beta Thalassemia โ 12 Common Mutations Screening (Single) |
| Price (AED) | 1200 AED |
| Turnaround Time | 6-7 Working Days |
| Sample Type / Matrix | Peripheral Whole Blood (3-5 mL EDTA Vacutainer). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM. |
| Methodology Used | Endpoint Polymerase Chain Reaction (PCR) |
| ICD-10-CM Code | D56.1 (Beta Thalassemia) |
| LOINC Code | 2472-2 (HBB gene mutation analysis) |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. DHA License Number: 1143 | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians